Johnson & Johnson’s Janssen ended its collaboration and licensing agreements with Bavarian Nordic concerning vaccines for hepatitis B virus and human papillomaviruses.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,